NICD inhibits cell proliferation and promotes apoptosis and autophagy in PC12 cells

Bo Li1, Ping Duan1, Xuefei Han2

  • 1Department of Physiology, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China.

Insights

Overexpressing the Notch1 intracellular domain (NICD) in pheochromocytoma cells promotes apoptosis and inhibits proliferation. This suggests NICD may be a potential therapeutic target for pheochromocytoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Pheochromocytoma, an adrenal medulla tumor, is currently only treated by surgical resection.
  • The Notch1 signaling pathway is a potential therapeutic target, but the role of its intracellular domain (NICD) in pheochromocytoma is unclear.

Purpose of the Study:

  • To investigate the effect of Notch1 intracellular domain (NICD) overexpression on pheochromocytoma cell growth and identify underlying mechanisms.

Main Methods:

  • Utilized a tetracycline-inducible system for NICD overexpression in the PC12 pheochromocytoma cell line.
  • Assessed cell cycle distribution and apoptosis using flow cytometry.
  • Examined autophagy-related protein expression (LC3B, Beclin 1, ATG5, ATG7) via Western blot analysis.

Main Results:

  • NICD overexpression significantly promoted apoptosis and suppressed proliferation by inducing S-phase arrest.
  • NICD stimulation led to increased expression of autophagy markers: LC3B, Beclin 1, ATG5, and ATG7.

Conclusions:

  • NICD overexpression in pheochromocytoma cells induces apoptosis, inhibits proliferation, and stimulates autophagy.
  • These findings highlight the potential of NICD as a therapeutic strategy for pheochromocytoma.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.6K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.0K